FENNEC PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss

The total revenue of FRX for the last quarter is 13.26 M CAD, and it's 51.74% higher compared to the previous quarter. The net income of Q4 23 is -3.65 M CAD.